| Name | Address | City |
|---|---|---|
| Brightview | 101 N lynnhaven rd suite #100 | Virginia Beach |
| Behavioral Health Group Virginia Beach Treatment Center | 5715 Princess Anne Rd | Virginia Beach |
| Virginia Beach Methadone Clinics | 1728 Virginia Beach Blvd Suite 113 | Virginia Beach |
| Virginia Beach Psychiatric Center | 1100 1st Colonial Road | Virginia Beach |
| Meridian Psychotherapy Services | 4509 WhiteChapel Drive | Virginia Beach |
| BHG Chesapeake Treatment Center | 3322 Western Branch Blvd A | Chesapeake |
| Affinity Healthcare Group, LLC | 3356 Western Branch Blvd. | Chesapeake |
| Behavioral Healthcare Services | 1811 King Street | Portsmouth |
| BHG Elizabeth City Treatment Center | 105 Medical Drive | Elizabeth City |
| BHG Newport News Treatment Center | 6000 B Jefferson Ave. | Newport News |
| American Addiction Treatment Center Newport News | 12695 McManus Blvd Building 2 | Newport News |
| BrightView Newport News | 11745 Jefferson Ave #10B | Newport News |
| Norfolk Community Services Board | 7460 Tidewater Drive | Norfolk |
| BHG Chesapeake South Treatment Center | 109 Wimbledon Square Ste H | Chesapeake |
| Crossroads Treatment Centers Suffolk | 1258 Holland Road | Suffolk |
| Department of Behavioral Services | 505 Washington St. | Portsmouth |
| Hampton Roads Clinic | 2712 Washington Avenue | Newport News |
No results found!
Starting opioid use disorder treatment in Virginia Beach
Virginia Beach sits at the center of Hampton Roads, and people here can reach both kinds of medication treatment for opioid use disorder (OUD) without leaving the region. Opioid treatment programs that dispense methadone operate in the city and in neighboring Norfolk, Chesapeake, Portsmouth, and Newport News, while buprenorphine and naltrexone are prescribed in doctors’ offices across the area and, increasingly, by telehealth. That mix matters: it means the medication you and a clinician choose, not just what happens to be nearby, can guide where you go. The listings above show programs serving Virginia Beach and the wider Hampton Roads area. You can call one directly or use the helpline on this page to talk through a first step.
Your medication options and where each one comes from
Three medications are approved to treat OUD, and where you get each one differs. Methadone for opioid use disorder is provided only through licensed opioid treatment programs, not regular pharmacies, so it involves going to a program, at least daily at first. Buprenorphine, including Suboxone and other buprenorphine-naloxone products, plus the extended-release monthly injection Sublocade, can be prescribed in a doctor’s office and filled at a pharmacy, or provided through a clinic. Naltrexone, including the monthly Vivitrol injection, can be prescribed by any licensed provider, but treatment starts only after a person has stopped using opioids for a set time, which is why timing is planned with a clinician.
The two settings behind these medications are worth understanding. An opioid treatment program (OTP) is the clinic model built around methadone and structured dosing. Office-based opioid treatment (OBOT) is care delivered in a regular medical practice, usually with buprenorphine or naltrexone. Virginia built a specific OBOT model into its Medicaid benefit, so office-based care is well established here. If you are weighing the trade-offs, how methadone and Suboxone compare is a useful starting point, and the overview of what a methadone clinic involves explains the OTP side in more detail.
What the first visit looks like
Starting treatment begins with an intake assessment, where a clinician reviews your history and, with you, decides on a medication and setting. Some programs offer same-day or walk-in starts; ask when you call, since availability changes. One practical point matters if you have been using fentanyl: starting buprenorphine too soon after fentanyl can trigger sudden, severe withdrawal (called precipitated withdrawal), because fentanyl lingers in the body. A clinician plans the timing of that first dose to avoid it, and methadone induction follows a different, gradual schedule. This is a question to raise directly at intake, not something to manage alone. For more on getting started, see treatment options after fentanyl use and the broader guide to opioid addiction treatment.
Take-home doses, telehealth, and current rules
Federal rules updated in 2024 expanded take-home methadone doses, up to a 28-day supply for patients who are stable in treatment, and the program decides eligibility based on your progress. Those same rules let treatment begin by telehealth and allowed mobile medication units. For buprenorphine, telehealth is especially flexible right now: as of July 2026, it can be started through telehealth, including by phone in many cases, without a prior in-person visit. Those telehealth rules run through the end of 2026 and are still being finalized, so confirm current options with a provider. Methadone for OUD remains dispensed through an OTP even when a visit starts online. If you are transferring into the area or returning after a gap, ask a program about guest dosing and how it handles keeping your dose consistent through a change; longer-term methadone maintenance treatment is standard, effective care, not an unfinished step.
Paying for treatment in Virginia
Virginia’s Medicaid program covers all three medications for OUD. Coverage runs through the Addiction and Recovery Treatment Services (ARTS) benefit, which the Department of Medical Assistance Services (DMAS) launched in 2017 and which built out a statewide network of office-based providers alongside the clinics. If you have Medicaid or qualify for it, methadone, buprenorphine, and naltrexone are covered benefits, and DMAS reports that most Virginia Medicaid members with an OUD diagnosis now receive one of these medications. Private insurance and Medicare cover MOUD as well, and many programs offer self-pay or sliding-scale options. Ask each program what it accepts when you call, since specifics vary by provider.
The local overdose picture, and why treatment is the response
Virginia has seen a steep, recent drop in overdose deaths. The Virginia Department of Health reported 1,548 drug overdose deaths among state residents in 2024, a 37% decrease from 2023, with fentanyl and related synthetic opioids still involved in roughly two-thirds of those deaths. In the Hampton Roads region that includes Virginia Beach, public health officials have described the decline as real but uneven across communities. Officials attribute much of the improvement to wider naloxone access and more people getting into treatment. That is the practical takeaway here: effective medication treatment is available across Virginia Beach and Hampton Roads, and getting into care is the step that most changes the odds. You can start with the listings above or the helpline on this page. For background on the condition itself, see this overview of opioid addiction.
Pregnancy, the justice system, and other specific situations
Some situations carry added questions. For pregnant patients, methadone and buprenorphine are the recommended standard of care, and staying in treatment is safer for both parent and baby than stopping; providers monitor for neonatal opioid withdrawal syndrome (NOWS) and coordinate care. Fear of child-welfare involvement keeps some pregnant patients from seeking help, but treatment is the course clinicians and public health guidance recommend, and Virginia’s programs work within confidentiality protections. People entering treatment through drug court, probation, or reentry from incarceration can ask a program whether it accepts their referral and provides any documentation required. See methadone and pregnancy for more, and guidance for families supporting someone through this.
Naloxone and overdose safety
Naloxone, the medication that reverses an opioid overdose, is available over the counter and through pharmacies and community programs. In Virginia, a statewide standing order lets any pharmacy dispense it without an individual prescription, and the REVIVE! program, run by the Department of Behavioral Health and Developmental Services with the Virginia Department of Health, offers free training and naloxone across the state. Virginia’s Good Samaritan protections can shield someone who calls for help during an overdose in good faith. Carrying naloxone makes sense for anyone using opioids or living with someone who does, and a return to use is a common, manageable part of recovery, not a failure. See how naloxone works in the context of a methadone overdose.
Common questions about treatment in Virginia Beach
Do I have to go to a clinic every day?
At first, methadone usually means daily visits to an OTP, but stable patients can earn take-home doses, now up to a 28-day supply under 2024 federal rules, at the program’s discretion. Buprenorphine and naltrexone are typically prescribed in an office and filled at a pharmacy, so they do not involve daily clinic visits.
Can I start buprenorphine by phone?
Often yes. As of July 2026, buprenorphine can be started by telehealth, including audio-only in many cases, without a prior in-person visit. These flexibilities are current through the end of 2026 and still being finalized, so confirm with a provider what applies when you call.
Which medication is best?
There is no single best medication; methadone, buprenorphine, and naltrexone work differently and suit different people and situations. This is a decision to make with a clinician who knows your history. A comparison of methadone and Suboxone can help you prepare for that conversation.
Will Medicaid cover it?
Virginia Medicaid covers all three medications through the ARTS benefit administered by DMAS. Private insurance and Medicare generally cover MOUD as well. Ask each program what plans it accepts and whether self-pay or sliding-scale options are available.
Can I get treatment while pregnant?
Yes, and it is recommended. Methadone and buprenorphine are the standard of care during pregnancy, and staying in treatment is safer than stopping. Providers coordinate care and monitor the newborn. See more answers to common treatment questions.
Last reviewed
Last reviewed July 2026.
Sources
- Virginia Department of Health, Drug Overdose Data (2024 overdose deaths and fentanyl involvement), 2026. https://www.vdh.virginia.gov/drug-overdose-data/
- Virginia Department of Medical Assistance Services, Addiction and Recovery Treatment Services (ARTS) benefit, coverage of MOUD, 2024. https://www.dmas.virginia.gov/for-providers/benefits-services-for-providers/behavioral-health/addiction-and-recovery-treatment-services/
- Virginia Department of Health, Statewide Naloxone Standing Order, March 2024. https://www.vdh.virginia.gov/content/uploads/sites/134/2024/03/Naloxone-Standing-Order_3-5-2024.pdf
- SAMHSA and Federal Register, 42 CFR Part 8 final rule (take-home methadone, telehealth initiation), 2024. https://www.samhsa.gov/
- DEA and HHS, Fourth Temporary Extension of Telemedicine Flexibilities and Expansion of Buprenorphine Treatment via Telemedicine Encounter, effective 2026. https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled
- WHRO Public Media, reporting on Hampton Roads overdose trends, January 2026. https://www.whro.org/health/2026-01-27/data-shows-virginias-opioid-crisis-swept-from-the-mountains-into-the-cities-hampton-roads-sees-both-the-progress-and-the-gaps
MethadoneCenters.com is a referrer service that provides information about addiction treatment practitioners and facilities. It is not a medical provider or treatment facility and does not provide medical advice. The information provided is not a substitute for professional treatment advice.
Calls to any general helpline on this page may be answered by a paid advertiser. There is no obligation to enter treatment.